Company Financials

SK Biopharmaceuticals Co. Ltd Financials

South Korean won

business SK Biopharmaceuticals Co. Ltd Company Profile

Main Stock Listing

KRX: 326030

Market Capitalization ₩7.338 Trillion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE
Forward PE 26.17
Price to Sales TTM ₩12.70
Price to Book MRQ
Enterprise to Revenue 12.26
Enterprise to EBITDA 54.75

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 43.46%
Operating Margin 17.78%
Return on Assets TTM 7.79%
Return on Equity TTM 50.86%

Income Statement

Revenue TTM ₩577,998,815,232
Revenue per Share TTM ₩7380.60
Quarterly Revenue Growth 26.70%
Gross Profit TTM ₩536,345,018,368
EBITDA ₩226,699,263,310
Net Income to Common TTM ₩251,210,579,968
Diluted EPS TTM
Quarterly Earnings Growth YoY 81.60%

Balance Sheet

Total Cash MRQ ₩268,694,634,496
Total Cash per Share MRQ ₩3431.02
Total Debt MRQ
Total Debt to Equity MRQ 21.08
Current Ratio MRQ 1.84
Book Value per Share MRQ

Cash Flow

Operating Cash Flow TTM ₩99,766,591,488
Levered Free Cash Flow TTM ₩40,085,725,184

326030 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 78,313,250
Float Shares 28,059,637
Avg 10 Volume 163,730
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 64.18%
% Held by Institutions 13.61%

Stock Price Summary

Beta 0.89
Fifty Two Week Low ₩72600.00
Fifty Two Week High ₩130000.00
Fifty Two Week Change 12.58%
Day 50 MA ₩94750.00
Day 200 MA ₩105763.00

Dividends and Splits

Forward Annual Dividend Rate
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate
Trailing Annual Dividend Yield %
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date